Takeshi Aiyama
Overview
Explore the profile of Takeshi Aiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wakizaka K, Shichi S, Aiyama T, Asahi Y, Nagatsu A, Orimo T, et al.
Ann Surg Open
. 2024 Dec;
5(4):e523.
PMID: 39711678
Objective: This study investigated the risk factors and management of portal vein thrombosis (PVT) after hepatectomy. Background: PVT after hepatectomy can cause liver dysfunction and portal hypertension, and may be...
2.
Asahi Y, Kakisaka T, Kamiyama T, Orimo T, Shimada S, Nagatsu A, et al.
Hepatol Res
. 2024 Jul;
PMID: 39058650
Aim: This study was undertaken to evaluate the outcome of curative liver resection, (LR) of Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma (BCLC-C HCC) after tyrosine kinase inhibitors (TKIs)...
3.
Shichi S, Sugiyama K, Asahi Y, Shirakawa C, Nakamoto H, Kimura S, et al.
Cancer Med
. 2024 May;
13(9):e7238.
PMID: 38716625
Background: Intrahepatic cholangiocarcinoma (ICC) has a high recurrence rate and a poor prognosis. Thus, the development of effective treatment and prognostic biomarkers is required. High expression of diacylglycerol kinase alpha...
4.
Wakizaka K, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, Aiyama T, et al.
Ann Surg Oncol
. 2023 Oct;
31(1):262-271.
PMID: 37814183
Background: Wnt5a is the key ligand of the noncanonical Wnt pathway, and receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a receptor associated with Wnt5a. The association between the noncanonical...
5.
Tsuzaka S, Aiyama T, Kamachi H, Kakisaka T, Orimo T, Nagatsu A, et al.
Microsurgery
. 2023 Apr;
43(6):606-610.
PMID: 37016794
Chylous ascites, the leakage of lymphatic fluid into the abdominal cavity caused by lymphatic fluid stasis or lymphatic vessel damage, can be treated by lymphaticovenous anastomosis (LVA). We report rarely...
6.
Sano S, Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, et al.
Int Cancer Conf J
. 2023 Jan;
12(1):7-13.
PMID: 36605836
Although systemic treatment for hepatocellular carcinoma has advanced after the development of tyrosine kinase inhibitors such as sorafenib and lenvatinib, the effectiveness of a single tyrosine kinase inhibitor in survival...
7.
Orimo T, Kamiyama T, Kakisaka T, Nagatsu A, Asahi Y, Aiyama T, et al.
Ann Surg Oncol
. 2022 Sep;
29(13):8436-8445.
PMID: 36100832
Background: A single hepatocellular carcinoma (HCC) is a good indication for hepatic resection regardless of tumor size, but the surgical indications for cases with multiple HCCs remain unclear. Methods: We...
8.
Tsuzaka S, Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Nagatsu A, et al.
Surg Case Rep
. 2022 Mar;
8(1):47.
PMID: 35307790
Background: Although there is no established treatment strategy for liver metastasis of leiomyosarcoma, liver resection has been reported to be effective in some cases. However, almost all liver resections performed...
9.
Kamiyama T, Orimo T, Wakayama K, Kakisaka T, Shimada S, Nagatsu A, et al.
Integr Cancer Ther
. 2022 Jan;
21:15347354211073066.
PMID: 35075934
Purpose: Active hexose-correlated compound (AHCC), a standardized extract of cultured Lentinula edodes mycelia, exerts antitumor effects through anti-inflammatory and immune-modulatory functions. Adjuvant therapy for patients with hepatocellular carcinoma (HCC) who...
10.
Asahi Y, Kamiyama T, Kakisaka T, Orimo T, Shimada S, Nagatsu A, et al.
World J Gastrointest Surg
. 2021 Nov;
13(10):1245-1257.
PMID: 34754392
Background: The prognosis of advanced hepatocellular carcinoma (HCC) that is not indicated for curative hepatectomy remains poor, despite advances in the treatment of HCC, including the development of tyrosine kinase...